Futramed Inc, based in Sandy, UT, is a pioneering company dedicated to providing affordable solutions for individuals struggling with pain, substance abuse, and other physical and behavioral limitations. Specializing in TCES technology, Futramed aims to reduce opioid consumption and dependence through their patented medical device, inspired by the work of Dr. Aim Limoge of Paris, France.
With a focus on innovation and clinical benefits, Futramed's transcutaneous electrical cranial stimulator has garnered attention for its ability to stabilize, reduce, or replace dosages of opioids in the treatment of pain and Opiate Withdrawal Syndrome. The company's commitment to advancing healthcare solutions is exemplified by their CE Mark Certification and U.S. Patent approval, positioning them as leaders in the field of addiction relief and pain management.
Generated from the website